Adma Biologics, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ADMA

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

400,019

Value ($000)

7,296

Weight

0.0%

2023 Q1 - 2025 Q4 (12 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	7,296	0.0%	400,019	12/31/2025
2025 Q3	11/14/2025	5,730	0.0%	390,828	9/30/2025
2025 Q2	8/14/2025	17,169	0.0%	942,851	6/30/2025
2025 Q1	5/19/2025	16,201	0.0%	816,590	3/31/2025
2024 Q4	2/14/2025	8,773	0.0%	511,526	12/31/2024
2024 Q3	11/14/2024	10,194	0.0%	509,967	9/30/2024
2024 Q2	8/14/2024	5,992	0.0%	535,987	6/30/2024
2024 Q1	5/15/2024	1,447	0.0%	219,287	3/31/2024
2023 Q4	2/14/2024	846	0.0%	187,197	12/31/2023
2023 Q3	11/13/2023	597	0.0%	166,628	9/30/2023
2023 Q2	8/11/2023	457	0.0%	138,128	6/30/2023
2023 Q1	5/15/2023	457	0.0%	138,128	3/31/2023